Replies to post #224472 on Biotech Values

[DewDiligence]

The quote about ALDR that was attributed to NVS in the Reuters piece I posted appears to have been taken out of context.

[DewDiligence]

LUND.CO acquires ALDR for $18/sh in cash—(+CVR)—an 84% premium to Friday’s close:

https://finance.yahoo.com/news/lundbeck-acquire-alder-biopharmaceuticals-company-055552277.html

The nominal deal value is $1.95B.